Fortis Healthcare Reports Strong Q1 FY27 Performance

Consolidated Revenue: ₹2,545.03 crore
Consolidated Net Profit: ₹272.80 crore

Reader Takeaway: Revenue and profit growth driven by core segments, offset by ongoing legal matters.

What just happened

Fortis Healthcare announced its financial results for the quarter ended June 30, 2026 (Q1 FY27). The company posted consolidated revenue of ₹2,545.03 crore, a rise from ₹2,364.67 crore in the previous quarter and ₹2,166.72 crore in the same quarter last year. Consolidated net profit for the quarter was ₹272.80 crore.

Standalone revenue from operations was ₹489.45 crore, with a standalone net profit of ₹47.78 crore for the quarter.

The company's Board has recommended a final dividend of ₹1.00 per equity share for the financial year ended March 31, 2026.

Why this matters

The results indicate sustained growth in Fortis Healthcare's operations. The revenue and profit figures demonstrate the company's ability to expand its top and bottom lines. The recommended dividend offers a direct return to shareholders, signaling financial health and confidence.

The backstory

Fortis Healthcare has been navigating complex legacy issues involving investigations by agencies like SFIO, EOW, and SEBI concerning past transactions with erstwhile promoters. Management has previously stated that provisions have been made for these matters, aiming to limit future financial impact.

What changes now

Shareholders will receive a dividend, subject to approval. The company continues its operational expansion, with healthcare and diagnostics segments showing revenue contributions of ₹2,186.67 crore and ₹406.54 crore respectively. The appointment of B S R & Co. LLP as tax auditors for FY 2025-26 is a routine administrative step.

Risks to watch

Ongoing investigations by SFIO, EOW, and SEBI related to historical transactions remain a key watch point. While management expects no further material impact, any adverse developments could affect the company's reputation and financial performance.

Peer comparison

(Peer comparison data not available in the filing)

Context metrics (time-bound)

Consolidated Revenue:
Q1 FY27: ₹2,545.03 crore
Q4 FY26: ₹2,364.67 crore
Q1 FY26: ₹2,166.72 crore

Consolidated Net Profit:
Q1 FY27: ₹272.80 crore

Standalone Revenue:
Q1 FY27: ₹489.45 crore
Q4 FY26: ₹460.73 crore
Q1 FY26: ₹433.03 crore

Standalone Net Profit:
Q1 FY27: ₹47.78 crore

Final Dividend recommendation: ₹1.00 per equity share for FY26.

What to track next

Investors should monitor any updates on the ongoing regulatory investigations and the company's financial performance in subsequent quarters. The successful resolution of brand ownership disputes also remains a factor to observe.